A company called Oxford Industries had some not-so-good results and their stock price went down a lot. This made other companies' stock prices go down too, because they are all connected in the market. The FDA is a group that decides if medicine can be sold or not, and they took more time to decide about one medicine for a sickness called Classic Galactosemia. Some people bought and sold these company stocks before the market opened, and some of them made good choices while others did not. Read from source...

1. The title is misleading and sensationalist, as the article does not focus on Oxford Industries but rather mentions it briefly along with other stocks that are moving lower in pre-market trading. A more accurate title would be "Pre-Market Update: Stocks Moving Lower On Monday" or something similar.
2. The article does not provide enough context and background information about the companies and their situations, making it difficult for readers to understand the reasons behind the stock price movements. For example, why did Applied Therapeutics have a negative FDA decision? What are the challenges facing Toyota Motor Corporation in terms of sales?
3. The article uses vague and general language, such as "volatility", "weak results", "short report" without explaining what these terms mean or how they affect the stock performance. This makes the article less informative and credible for readers who are looking for specific details and insights.
4. The article ends with a promotional section that tries to persuade readers to join Benzinga's services, which is irrelevant to the main topic of the article and may undermine its journalistic integrity. This section should be removed or separated from the actual news content.